Nebius (NL) shares (NBIS) › Analysis

Nebius (NL) shares (NBIS) stock analysis, December 4, 2025: NBIS clears $100 support after a -30% correction; can it retest $110?

Published December 4, 2025 · NBIS chart, levels and live analysis

Key Updates

Nebius shares advanced +3.23% to $102.22, decisively breaking above the $100 psychological barrier and establishing this level as support after testing it multiple times over the past week. The stock has now gained +7.95% over five trading days, recovering from the month-long correction that saw shares decline -7.53% from November highs. This consolidation above $100 validates the bullish reversal pattern observed since late November and positions NBIS for a potential retest of the $110-120 resistance zone. The investment thesis remains firmly intact, with no material changes to the fundamental narrative despite recent volatility.

Current Trend

NBIS exhibits exceptional year-to-date momentum with +269.03% gains, ranking among the top-performing technology stocks in 2025. The six-month performance of +159.51% reflects the transformational impact of hyperscaler contract announcements beginning in Q3. Following a healthy -30% correction from November highs around $130, the stock has established a new support base at $95-100, with the current price of $102.22 representing a successful breakout above this consolidation range. The recent five-day surge of +7.95% signals renewed institutional accumulation, while the one-month decline of -7.53% represents normal profit-taking after a parabolic advance. Key resistance levels remain at $110 (recent swing high) and $130 (all-time high), while support has solidified at $95-100 (20-day moving average zone).

Investment Thesis

Nebius represents a pure-play investment in AI infrastructure buildout, positioned as a critical enabler for hyperscaler AI model training and deployment. The company has secured over $20 billion in multi-year contracts with Microsoft ($17.4 billion) and Meta ($2.9 billion over five years), providing exceptional revenue visibility through 2026 and beyond. Management targets aggressive growth from 2025 ARR of $900M-$1.1B to 2026 ARR of $7B-$9B, representing a 6-8x increase driven by hyperscaler capacity commitments. The company operates near full utilization of computing capacity and is approaching EBITDA profitability despite massive capital expenditure requirements. Analyst consensus maintains a Strong Buy rating with an average price target of $159-164, implying 56-60% upside from current levels. The thesis centers on Nebius capturing meaningful share of the estimated $200+ billion AI infrastructure market through 2030, leveraging first-mover advantages with tier-one hyperscaler clients.

Thesis Status

The investment thesis remains fully intact and has strengthened since the previous report. The stock's ability to consolidate above $100 and resume its upward trajectory validates the structural demand thesis for AI infrastructure. Recent analysis confirms the company is on track to deliver the 2026 ARR surge that the market has not fully priced in, with shares gaining 7.2% since that publication while outperforming the S&P 500's 4.3% gain. The recovery from the -30% correction demonstrates that institutional investors view the selloff as a buying opportunity rather than a fundamental deterioration. Hedge fund and institutional buying activity has accelerated during the recent dip, confirming sophisticated investors are accumulating positions. The primary thesis risks—high leverage ($4.5+ billion debt), aggressive CapEx requirements, and potential dilution—remain unchanged but are offset by the exceptional revenue growth trajectory and path to EBITDA profitability.

Key Drivers

The immediate catalyst for the +3.23% advance appears to be continued institutional accumulation following the recent correction, with hedge funds increasing positions after the -30% drawdown from highs. The stock is benefiting from a broader rotation back into AI infrastructure names as investors digest the massive contract wins with Microsoft and Meta. Analyst commentary highlighting the market's underappreciation of the 2026 ARR growth surge is gaining traction, with valuation models indicating 61-159% upside potential. The upcoming UBS Global Technology and AI Conference on December 3rd may serve as a catalyst for management to provide additional color on capacity utilization and contract pipeline visibility. Technical factors also support the advance, with the stock successfully retesting and holding the $100 level as support after multiple attempts, triggering momentum-based buying algorithms.

Technical Analysis

NBIS has completed a textbook correction and consolidation pattern, declining -30% from the $130 November high to establish support at $95-100. The current price of $102.22 represents a decisive breakout above the consolidation range on expanding volume over the past five sessions (+7.95%). The stock has formed a higher low pattern at $95 compared to the previous swing low at $83, indicating strengthening buying pressure at each dip. Resistance levels are clearly defined at $110 (recent swing high from late November) and $130 (all-time high), with intermediate resistance at $115. Support has now shifted higher to $100 (psychological level and breakout point) and $95 (20-day moving average). The relative strength index likely remains in bullish territory above 50, while the stock trades above both its 20-day and 50-day moving averages. Volume patterns suggest institutional accumulation, with higher volume on up days versus down days over the past week. The price action demonstrates classic consolidation-breakout behavior typical of growth stocks digesting rapid gains before the next leg higher.

Bull Case

  • Exceptional ARR growth trajectory with 6-8x increase targeted from 2025 to 2026: Management guidance of $7B-$9B ARR by end of 2026 versus $900M-$1.1B in 2025 represents unprecedented growth visibility, driven by contracted capacity with Microsoft and Meta. Valuation models indicate 61-159% upside as this growth materializes, with the market significantly underestimating the magnitude of the 2026 revenue surge.
  • Over $20 billion in contracted revenue with tier-one hyperscalers provides exceptional visibility: The $17.4 billion Microsoft contract and $2.9 billion five-year Meta agreement eliminate revenue uncertainty through 2026-2030. Near-full utilization of computing capacity demonstrates strong execution and positions the company to monetize additional capacity as it comes online.
  • Strong analyst consensus with 56-60% upside to average price target: Wall Street maintains a Strong Buy rating with price targets of $159-164, supported by 73-80% projected upside from multiple analysts. Citizens JMP initiated coverage with a $175 price target, representing the most bullish Street view.
  • Approaching EBITDA profitability despite massive growth investments: The company is nearing EBITDA profitability while simultaneously funding aggressive capacity expansion, demonstrating operational leverage and unit economics that improve with scale. This milestone would validate the business model and support multiple expansion.
  • Institutional and hedge fund accumulation during recent correction: Sophisticated investors increased positions during the -30% drawdown, viewing the selloff as a strategic entry point. This institutional support provides a demand floor and suggests confidence in the long-term thesis despite near-term volatility.

Bear Case

  • High leverage with debt exceeding $4.5 billion creates financial risk: Aggressive capital expenditure plans and debt levels above $4.5 billion expose the company to refinancing risk and interest rate sensitivity. Any disruption to the growth trajectory could impair debt servicing capacity and force dilutive capital raises.
  • Concerns about circular financing structures with hyperscaler clients: Questions about circular financing arrangements with Microsoft and Meta could undermine confidence in revenue quality. If these contracts involve vendor financing or non-traditional structures, actual cash generation may disappoint relative to reported ARR.
  • Extreme valuation multiples with P/E ratio exceeding 490x: High valuation concerns with P/E over 490 and price-to-book of 5x versus industry average of 3.4x leaves little room for execution missteps. The stock prices in perfect execution of the aggressive 2026 ARR targets with no margin for disappointment.
  • Significant dilution risk from equity financing needs: Significant CapEx and dilution risks require close monitoring as the company funds capacity expansion. Additional equity raises could dilute existing shareholders by 20-30% or more, offsetting revenue growth on a per-share basis.
  • Vulnerability to broader AI infrastructure sector selloffs: The stock experienced a 35% decline from recent highs amid broader AI sector concerns, demonstrating high beta to sector sentiment. AI datacenter stocks received 40-60% haircuts in recent weeks, and any renewed skepticism about AI infrastructure spending could trigger another sharp correction.
Get a message when the NBIS picture changes — the agent team watches the levels and the news for you.Create a free account

More NBIS analyses